Charles Zhu
Stock Analyst at LifeSci Capital
(1.83)
# 1474
Out of 5,219 analysts
26
Total ratings
55.00%
Success rate
22.40%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Repare Therapeutics | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Dec 13, 2024 | |
Tango Therapeutics | Maintains: Buy | 18 8 | 2.99 | 167.56% | 3 | Nov 7, 2024 | |
Macrogenics | Upgrades: Buy | 12 | 3.21 | 273.83% | 4 | Nov 7, 2023 | |
Merus | Maintains: Strong Buy | 46 48 | 42.86 | 11.99% | 6 | Aug 8, 2023 | |
Nuvalent | Initiates Coverage On: Buy | 56 | 87.09 | -35.7% | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 22 | 5.45 | 303.67% | 1 | Jul 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 26 | 8.35 | 211.38% | 3 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 32 | 25.97 | 23.22% | 3 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 14 | 13.86 | 1.01% | 2 | May 5, 2022 |